Toshiaki Nishihata
Director/Board Member at RIBOMIC INC.
Profile
Toshiaki Nishihata is an Independent Outside Director at Ribomic, Inc. and an Outside Director at Trans Chromosomics, Inc. He was previously the President & Chief Executive Officer at Santen, Inc. and the Director, Head-Research & Development Division at Santen Pharmaceutical Co., Ltd.
He also served as a Director at Santen Holdings U.S., Inc. and as a Manager-Pharmaceutical Development Department at Upjohn Pharmaceuticals Ltd.
Toshiaki Nishihata active positions
| Companies | Position | Start |
|---|---|---|
| RIBOMIC INC. | Director/Board Member | 2016-05-31 |
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Director/Board Member | 2018-01-31 |
Former positions of Toshiaki Nishihata
| Companies | Position | End |
|---|---|---|
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | President | - |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Director/Board Member | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| RIBOMIC INC. | Health Technology |
| Private companies | 4 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Santen Holdings U.S., Inc.
Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Finance |
| Upjohn Pharmaceuticals Ltd. | |
Trans Chromosomics, Inc.
Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Commercial Services |
- Stock Market
- Insiders
- Toshiaki Nishihata